Allentown
45° F
Scattered Clouds
Scattered Clouds

FDA tightens tanning bed rules

By Rosa Duarte, Reporter, RDuarte@wfmz.com
Published On: May 07 2013 07:00:00 PM CDT
Updated On: May 07 2013 10:06:33 PM CDT

FDA tightens tanning bed rules

The FDA is turning up the heat on tanning salons in a new list of proposals it announced Monday.

Among them are warning labels to discourage younger people under the age of 18 not to use tanning beds.

According to the American Academy of Dermatology, those who use tanning beds are 75 percent more likely to develop melanoma, the deadliest form of skin cancer.

The FDA says the proposals are not just to deter young people from tanning but also to enhance oversight of tanning beds and similar devices.

For Krysti Fasching, owner of Wake n' Bake tanning salon in Allentown, the new proposals might be bad for business.

“I would have never thought that I would be in a business that people would think it was quote end quote 'harmful' to other people” said Fasching.

The proposals include warning labels not just in the tanning booth but on the bed itself listing the dangers of tanning as well as a warning that people who are repeatedly exposed should see their doctor on a regular basis to check for possible skin cancer.

According to the FDA, in a recent study published by the journal Pediatrics, melanoma is the second most common form of skin cancer among women in their 20's and the third most common cancer in men in the same age group.

The FDA also proposes to reclassify tanning devices from a Class I to a Class II medical device, which require a pre-market review to make sure the devices meet certain performance as well safety standards.

Despite what happens, Fasching says she's already making plans to keep her business going “That's why I want to keep up, I want to offer spray tanning, I want to start driving to people's houses. I don't want to be affected for what other people think about this business” she said.

The proposals will be published on the Federal Register website.

The FDA will take public comments for 90 days.